Arca
Skip to content
Tools
Tools

DNA polymerase catalytic subunit

Protein in Herpes simplex virus (type 1 / strain 17) that 9 drugs act on.

  • Drugs that act on it: 9
  • Approved: 9
  • In phases 1 to 3: 0
  • Sponsors: 9

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 9

Approved9

  • Acyclovir
  • Ganciclovir
  • Valganciclovir
  • Valacyclovir
  • Vidarabine
  • Foscarnet
  • Famciclovir
  • Cidofovir anhydrous
  • Penciclovir

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Human herpesvirus 1 DNA polymerase inhibitor.
        AcyclovirApprovedMerck & Co. (MSD)Small moleculeInhibitor53
        GanciclovirBoxed warningApprovedRocheSmall moleculeInhibitor35
        ValganciclovirBoxed warningApprovedCheplapharmSmall moleculeInhibitor33
        ValacyclovirApprovedGSKSmall moleculeInhibitor25
        VidarabineApprovedPfizerSmall moleculeInhibitor7
        FoscarnetBoxed warningApprovedClinigen HealthcareSmall moleculeInhibitor5
        FamciclovirApprovedNovartis PharmaceuticalsSmall moleculeInhibitor4
        Cidofovir anhydrousBoxed warningApprovedSymBio PharmaceuticalsSmall moleculeInhibitor3
        PenciclovirApprovedViatrisSmall moleculeInhibitor1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 37 in all, from ClinicalTrials.gov.
        A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Valacyclovir, AcyclovirPhase 2 / Phase 3Not yet recruitingMerck Sharp & Dohme LLCNov 5, 2026
        Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital HerpesValacyclovir, AcyclovirPhase 2Not yet recruitingGilead SciencesNov 3, 2026
        Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar WartsAcyclovirPhase 3Not yet recruitingAssiut UniversitySep 29, 2026
        CMV-CMI in csCMVi After HSCTFoscarnet, Valganciclovir, Ganciclovir—RecruitingThe First Affiliated Hospital of Soochow UniversityJul 7, 2026
        Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal NeuralgiaAcyclovirNot applicableNot yet recruitingBeijing Tiantan HospitalJun 29, 2026
        Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)Valacyclovir, AcyclovirPhase 3RecruitingCandel Therapeutics, Inc.Jun 22, 2026
        SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionValacyclovir, AcyclovirPhase 2RecruitingIcahn School of Medicine at Mount SinaiMay 19, 2026
        Letermovir vs Valganciclovir in CMV R+ Kidney TransplantValganciclovirPhase 4Not yet recruitingElisabeth KincaideMay 6, 2026
        Cord Blood Transplantation in Children and Young Adults With Blood CancerVidarabinePhase 2RecruitingMemorial Sloan Kettering Cancer CenterMay 5, 2026
        Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker EvaluationValacyclovir, AcyclovirNot applicableRecruitingDexiong HanApr 7, 2026
        Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and IIValganciclovir, Acyclovir, GanciclovirPhase 2Not yet recruitingUniversity of California, San FranciscoApr 7, 2026
        HOME-PE2 : Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism, no Clinical Severity Criteria, and Either Right Ventricular Dysfunction or Elevated Troponin: a Randomized Controlled TrialPenciclovirNot applicableNot yet recruitingUniversity Hospital, AngersApr 1, 2026
        A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaGanciclovirNot applicableRecruitingThe First Affiliated Hospital of Soochow UniversityMar 30, 2026
        Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic LymphohistiocytosisFoscarnet, GanciclovirNot applicableRecruitingBeijing Children's HospitalMar 23, 2026
        Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus InfectionValganciclovir, GanciclovirPhase 4Not yet recruitingHu BofeiMar 4, 2026
        Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant RecipientsValganciclovirPhase 4Active, not recruitingUniversity of GuadalajaraFeb 24, 2026
        A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCTCidofovir anhydrousPhase 3RecruitingSymBio PharmaceuticalsFeb 4, 2026
        Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV InfectionValganciclovir, GanciclovirPhase 2RecruitingThe Methodist Hospital Research InstituteFeb 3, 2026
        ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAseValganciclovir, GanciclovirPhase 2Not yet recruitingWits Health Consortium (Pty) LtdJan 30, 2026
        Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck RadiotherapyValacyclovirPhase 2Enrolling by invitationInstituto OncoclinicasJan 23, 2026
        Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade GliomaValacyclovirPhase 1 / Phase 2RecruitingTrogenix ltdJan 16, 2026
        Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster PainFamciclovirNot applicableNot yet recruitingBeijing Tiantan HospitalJan 15, 2026
        A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecValacyclovirPhase 2RecruitingCandel Therapeutics, Inc.Jan 12, 2026
        Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot StudyValganciclovir, GanciclovirNot applicableRecruitingNational Taiwan University HospitalDec 19, 2025
        Efficacy and Safety of Brivudine in the Treatment of Herpes ZosterFamciclovirPhase 4RecruitingPeking University Third HospitalAug 1, 2025
        Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster PainFamciclovirNot applicableNot yet recruitingXiaguang DuanJan 29, 2025
        Effect of Mechanical Ventilation on Radiofrequency Ablation in Atrial FibrillationFamciclovir—RecruitingKocaeli City HospitalJan 24, 2025
        A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South KoreaFoscarnet, Cidofovir anhydrous—RecruitingTakedaAug 15, 2024
        A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaVidarabinePhase 1RecruitingCity of Hope Medical CenterMar 7, 2023
        Study for Subjects With Relapsed/Refractory Non- Hodgkin LymphomaVidarabinePhase 1RecruitingImmunityBio, Inc.Nov 16, 2022
        Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin LymphomasVidarabinePhase 1Active, not recruitingDavid WaldJun 1, 2022
        Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant DiseasesVidarabinePhase 1 / Phase 2RecruitingFred Hutchinson Cancer CenterSep 10, 2019
        Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantVidarabinePhase 2Active, not recruitingFred Hutchinson Cancer CenterDec 19, 2018
        Pharmacokinetics of Drugs Administered to ChildrenFoscarnet—RecruitingDuke UniversityMar 29, 2018
        International Randomised Phase III Clinical Trial in Children With Acute Myeloid LeukaemiaVidarabinePhase 3Active, not recruitingUniversity of BirminghamMar 31, 2016
        Cidofovir Versus Best Supportive Care for Hemorrhagic CystitisCidofovir anhydrousPhase 2Active, not recruitingM.D. Anderson Cancer CenterFeb 14, 2011
        Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantFoscarnet—Active, not recruitingCity of Hope Medical CenterSep 13, 2010

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1872, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.